Kopran Ltd Share Price – NSE /  BSE

Pharmaceuticals, Small Cap

Net loss of Kopran reported to Rs 9.92 crore in the quarter ended September 2025 as against net profit of Rs 7.38 crore during the previous quarter ended September 2024. Sales declined 22.20% to Rs 117.91 crore in the quarter ended September 2025 as against Rs 151.56 crore during the previous quarter ended September 2024.

Powered by Capital Market - Live News

Kopran will hold a meeting of the Board of Directors of the Company on 12 November 2025.

Powered by Capital Market - Live News

Kopran Ltd gained 4.13% today to trade at Rs 163.7. The BSE Healthcare index is up 0.34% to quote at 44693.47. The index is down 0.96 % over last one month. Among the other constituents of the index, Aarti Pharmalabs Ltd increased 2.6% and Rainbow Childrens Medicare Ltd added 1.58% on the day. The BSE Healthcare index went up 7.92 % over last one year compared to the 1.11% surge in benchmark SENSEX.

Kopran Ltd has lost 8.09% over last one month compared to 0.96% fall in BSE Healthcare index and 0.54% drop in the SENSEX. On the BSE, 25 shares were traded in the counter so far compared with average daily volumes of 20242 shares in the past one month. The stock hit a record high of Rs 369.2 on 09 Sep 2024. The stock hit a 52-week low of Rs 156.5 on 08 Aug 2025.

Powered by Capital Market - Live News

Kopran announced that the 66th Annual General Meeting(AGM) of the company will be held on 11 September 2025.

Powered by Capital Market - Live News